SCHEMBL7424858

SCHEMBL7424858

CCCc1c(C(C)=O)c2ccc(C(N)=O)cc2n1Cc1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.47
ALOX5AP P20292 1/20 0.42
DPP4 P27487 3/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PLA2G2A P14555 2/20 0.39
TNF P01375 1/20 0.39
TP53 P04637 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421179 0.95 L3MBTL1 (0.43) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7426692 0.94 ALOX5AP (0.43) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7471798 0.92 L3MBTL1 (0.48) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7425177 0.91 ALOX5AP (0.45) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7421847 0.91 ALOX5AP (0.43) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL150104 0.91 L3MBTL1 (0.47) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
Morpholine SCHEMBL7426949 0.90 L3MBTL1 (0.40) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7416076 0.90 ALOX5AP (0.40) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7416079 0.90 ALOX5AP (0.40) L3MBTL1ALOX5APDPP4ALDH1A1MEN1
SCHEMBL7424518 0.90 ALOX5AP (0.43) L3MBTL1ALOX5APDPP4ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed